Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Justin Simmons

Vascular Surgery Grand Rapids, MI Doctor of Osteopathy

NPI 1235392598 CMS profile 328428

275 Michigan St Ne, Grand Rapids, MI 49503

Open in the dashboard

General payments

$3,525

83 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Justin Simmons of Grand Rapids, MI is reported in the CMS Open Payments database as having received $3,525 across 83 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 41st percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $489 13
2024 General $431 12
2023 General $514 18
2022 General $284 11
2021 General $480 10
2020 General $511 10
2019 General $815 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Justin Simmons
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Justin Simmons were reported at $489. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Justin Simmons Vascular Surgery median Middle half National median
2019 $815 $796 $226–$2,363 $163
2020 $511 $348 $118–$1,110 $114
2021 $480 $471 $158–$1,421 $132
2022 $284 $725 $222–$2,183 $149
2023 $514 $836 $257–$2,440 $160
2024 $431 $909 $252–$2,619 $164
2025 $489 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bard Peripheral Vascular, Inc. $785 5 payments
  2. Endologix, Inc. $506 7 payments
  3. W. L. Gore & Associates, Inc. $323 12 payments
  4. Cardiovascular Systems Inc. $279 7 payments
  5. Kerecis Limited $256 5 payments
  6. Boston Scientific Corporation $230 3 payments
  7. Abbott Laboratories $176 6 payments
  8. Cook Medical LLC $167 6 payments
  9. Ethicon US, LLC $78 3 payments
  10. Stryker Corporation $75 2 payments
  11. Other $651 27 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,882 79 payments
  2. Travel and Lodging $598 3 payments
  3. Education $46 1 payment
Products named General payments · program years 2019–2025
  1. Alto Abdominal Stent Graft System $316 4 payments
  2. Peripheral Orbital Atherectomy System $272 6 payments
  3. C3 Delivery System $182 5 payments
  4. Ranger $169 1 payment
  5. Kerecis Omega3 SurgiClose $159 2 payments
  6. Ovation $154 2 payments
  7. ALTO $135 1 payment
  8. Kerecis Omega3 Marigen Wound Care $132 1 payment
  9. Kerecis Omega3 Marigen Wound Care $132 1 payment
  10. Kerecis Omega3 Marigen Wound Care $132 1 payment
  11. Other $2,317 84 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

110

Median for Vascular Surgery: 122

Drug cost

$44,109

Median for Vascular Surgery: $14,135

Branded share of claims

100%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 28 $21,977
Xarelto Rivaroxaban Brand 14 $12,634
Brilinta Ticagrelor Brand 20 $8,520
Clopidogrel Clopidogrel Bisulfate Brand 48 $978

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 57 billing codes

Paid by Medicare

$68,948

Medicare's payments for the services billed

Medicare patients

346

Average age 74

Services billed

585

141 women, 205 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 52%
Arthritis 44%
Diabetes 40%
Chronic kidney disease 34%
COPD 31%
Atrial fibrillation 29%
Heart failure 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

83 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record